USD 1.47
(-3.29%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 7.16 Million USD | -23.52% |
2022 | 9.36 Million USD | -56.91% |
2021 | 21.74 Million USD | -31.33% |
2020 | 31.66 Million USD | -44.37% |
2019 | 56.91 Million USD | 5600.21% |
2018 | 998.45 Thousand USD | -48.01% |
2017 | 1.92 Million USD | 0.23% |
2016 | 1.91 Million USD | 251.31% |
2015 | 545.41 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 8.05 Million USD | 12.49% |
2024 Q2 | 11.46 Million USD | 42.25% |
2024 Q3 | 10.81 Million USD | -5.65% |
2023 Q2 | 7.89 Million USD | -13.55% |
2023 Q4 | 7.16 Million USD | -1.02% |
2023 Q3 | 7.23 Million USD | -8.35% |
2023 Q1 | 9.13 Million USD | -2.47% |
2023 FY | 7.16 Million USD | -23.52% |
2022 Q3 | 10.53 Million USD | -18.72% |
2022 FY | 9.36 Million USD | -56.91% |
2022 Q1 | 14.92 Million USD | -31.34% |
2022 Q4 | 9.36 Million USD | -11.11% |
2022 Q2 | 12.96 Million USD | -13.14% |
2021 Q3 | 26.24 Million USD | -25.39% |
2021 Q4 | 21.74 Million USD | -17.15% |
2021 FY | 21.74 Million USD | -31.33% |
2021 Q1 | 38.35 Million USD | 21.16% |
2021 Q2 | 35.17 Million USD | -8.31% |
2020 FY | 31.66 Million USD | -44.37% |
2020 Q4 | 31.66 Million USD | 14.17% |
2020 Q3 | 27.73 Million USD | 35.76% |
2020 Q2 | 20.42 Million USD | -55.86% |
2020 Q1 | 46.27 Million USD | -18.7% |
2019 FY | 56.91 Million USD | 5600.21% |
2019 Q4 | 56.91 Million USD | -24.88% |
2019 Q2 | 108.25 Million USD | 38.23% |
2019 Q3 | 75.76 Million USD | -30.01% |
2019 Q1 | 78.31 Million USD | 7743.32% |
2018 Q3 | 1.25 Million USD | 128.32% |
2018 Q1 | 1.14 Million USD | -40.46% |
2018 Q2 | 548.67 Thousand USD | -52.02% |
2018 Q4 | 998.45 Thousand USD | -20.3% |
2018 FY | 998.45 Thousand USD | -48.01% |
2017 Q4 | 1.92 Million USD | 191.94% |
2017 FY | 1.92 Million USD | 0.23% |
2017 Q3 | 657.85 Thousand USD | 0.0% |
2016 Q4 | 1.91 Million USD | 0.0% |
2016 FY | 1.91 Million USD | 251.31% |
2015 FY | 545.41 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
China Pharma Holdings, Inc. | 9.01 Million USD | 20.529% |
cbdMD, Inc. | 7.16 Million USD | 0.0% |
Zomedica Corp. | 13.18 Million USD | 45.645% |